Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meneveau

Showing results (251-260 of 290) with videos related to

Pageof 29
Sort By:
International Journal of Cardiology|October 22, 2019
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trialRidhima Goel, David Power, Didier Tchetche, et al.
JAMA|April 29, 2015
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trialPatrick Mismetti, Silvy Laporte, Olivier Pellerin, et al.
Clinical Cardiology|February 17, 2016
Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-GenerationJean-Philippe Collet, Johanne Silvain, Mathieu Kerneis, et al.
Archives of Cardiovascular Diseases|July 9, 2026
Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registryManveer Singh, Etienne Puymirat, Christophe Robin, et al.
European Heart Journal|May 24, 2018
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular InterventionsLorenz Räber, Gary S Mintz, Konstantinos C Koskinas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 26, 2018
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular InterventionsLorenz Räber, Gary S Mintz, Konstantinos C Koskinas, et al.
European Heart Journal. Acute Cardiovascular Care|October 11, 2021
Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trialPascal Lim, Clément Delmas, Olivier Sanchez, et al.
Bulletin Du Cancer|October 4, 2016
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté]Fanny Dénommé, Marie Kroemer, Philippe Montcuquet, et al.
Journal of the American College of Cardiology|March 25, 2017
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary EmbolismStavros V Konstantinides, Eric Vicaut, Thierry Danays, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Pageof 29

Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
International Journal of Cardiology|October 22, 2019
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trialRidhima Goel, David Power, Didier Tchetche, et al.
JAMA|April 29, 2015
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trialPatrick Mismetti, Silvy Laporte, Olivier Pellerin, et al.
Clinical Cardiology|February 17, 2016
Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-GenerationJean-Philippe Collet, Johanne Silvain, Mathieu Kerneis, et al.
Archives of Cardiovascular Diseases|July 9, 2026
Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registryManveer Singh, Etienne Puymirat, Christophe Robin, et al.
European Heart Journal|May 24, 2018
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular InterventionsLorenz Räber, Gary S Mintz, Konstantinos C Koskinas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 26, 2018
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular InterventionsLorenz Räber, Gary S Mintz, Konstantinos C Koskinas, et al.
European Heart Journal. Acute Cardiovascular Care|October 11, 2021
Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trialPascal Lim, Clément Delmas, Olivier Sanchez, et al.
Bulletin Du Cancer|October 4, 2016
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté]Fanny Dénommé, Marie Kroemer, Philippe Montcuquet, et al.
Journal of the American College of Cardiology|March 25, 2017
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary EmbolismStavros V Konstantinides, Eric Vicaut, Thierry Danays, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Patrick W Serruys, Scot Garg, et al.
Pageof 29